A major reclassification occurred with the redesignation of noninvasive encapsulated follicular variant of papillary thyroid carcinoma as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) due to its indolent nature. The aim of this study was to determine whether distinct cytomorphologic features could be identified on preoperative fine-needle aspiration (FNA) when NIFTP cases were compared with invasive follicular variant of papillary thyroid carcinoma (FVPTC) subtypes. METHODS: Thyroid resection cases with the diagnosis of FVPTC from 2012 to 2016 were reclassified as NIFTP, invasive encapsulated follicular variant of papillary thyroid carcinoma (IEFVPTC), and invasive FVPTC subtypes. Corresponding FNA specimens were retrieved and retrospectively reviewed. A univariate analysis using Fisher's exact test was performed to determine any differences in the frequencies of various cytomorphologic features among NIFTP, IEFVPTC, and FVPTC cases. A multivariate analysis was performed to identify any independent salient features that would be helpful in differentiating NIFTP from its invasive counterparts. RESULTS: The study population consisted of 93 cases, including 51 cases of NIFTP, 21 cases of IEFVPTC, and 21 cases of infiltrative FVPTC. Demographics such as age, sex, and tumor size were comparable across the 3 groups. A predominantly microfollicular pattern, an absence of nuclear pseudo-inclusions, and less frequent nuclear elongations and grooves were significantly more likely to be associated with NIFTP versus its invasive counterparts. The absence of nuclear pseudo-inclusions and the presence of a microfollicular pattern were the only independent predictors of a NIFTP diagnosis. CONCLUSIONS: This study demonstrates that NIFTP cases have distinguishing cytomorphologic characteristics in comparison with invasive FVPTC cases.
INTRODUCTION
The sensitivity of papillary thyroid cancer detection has increased in previous decades, whereas thyroid cancer mortality has largely remained unchanged. 1 To eliminate the term cancer from the lexicon for those lesions that demonstrate indolent behavior, a group of expert clinicians and pathologists have recently revised the designation of a certain follicular variant of papillary thyroid carcinoma (FVPTC) subgroup (those FVPTCs showing complete encapsulation and lacking evidence of capsular and/or vascular invasion) to noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). 2 This nomenclature change currently affects the histologic evaluation at the time of final surgical resection. Preoperatively distinguishing indolent NIFTP tumors from the invasive subtypes (both invasive encapsulated follicular variant of papillary thyroid carcinoma [IEFVPTC] and infiltrative FVPTC) could have important diagnostic and therapeutic implications for patient management. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), introduced in 2008, has been widely adopted as the diagnostic classification system for the fineneedle aspiration (FNA) cytology of thyroid nodules. 3, 4 Because of the recent reclassification of some FVPTCs as NIFTPs, efforts are underway to assess the impact on cytologic diagnoses and the resultant risk of malignancy. 5 In the interim, a few studies have found that the introduction of the NIFTP terminology will result in a decrease in the risk of malignancy in all cytology categories, with the greatest impact being in the indeterminate categories, including atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), suspicious for follicular neoplasm/follicular neoplasm, and, to a lesser extent, suspicious for malignancy. 6, 7 In addition, only a few studies have examined the cytomorphologic differences between NIFTP and other entities such as classic papillary thyroid carcinoma (PTC), invasive FVPTC, and benign follicular lesions (adenoma/goiter). [8] [9] [10] [11] [12] [13] These studies have reported that NIFTPs are cytomorphologically distinct from benign follicular lesions (ie, follicular adenomas) and classic PTC. 8, 9, [11] [12] [13] However, it is still uncertain whether NIFTPs are cytomorphologically distinct from IEFVPTC subtypes because NIFTPs share many morphologic similarities with invasive FVPTC subtypes. [10] [11] [12] Therefore, currently, our ability to distinguish among these follicularpatterned tumors preoperatively is unresolved. The current published guidelines for clinical management recommend surgical intervention for some indeterminate diagnoses, namely, follicular neoplasm and suspicious for malignancy. Specifically, the 2016 American Thyroid Association and National Comprehensive Cancer Network guidelines recommend total thyroidectomy for patients with a cytologic diagnosis of suspicious for malignancy. These organizations do, however, acknowledge the importance of conservative management for lesions with probable good outcomes such as papillary microcarcinomas.
14 Because NIFTPs are no longer recognized as cancer, a more conservative approach such as lobectomy rather than total thyroidectomy may be warranted. Identifying distinct cytomorphologic features that may help to distinguish NIFTPs from their invasive counterparts preoperatively could have an impact on surgical decision-making. Therefore, the aim of this study was to compare the cytomorphology of NIFTP with that of invasive FVPTC subtypes (IEFVPTC and infiltrative FVPTC) with the goal of assessing how this new diagnostic entity could affect the preoperative cytologic evaluation of follicular-patterned tumors.
MATERIALS AND METHODS
The institutional review board approved this study. Thyroid resection cases (125 total) over a 4-year period (June 2012 to June 2016) with FVPTC in the diagnostic line were retrieved from the archives of the Yale-New Haven Hospital pathology database. The use of NIFTP as the diagnostic terminology was adopted in June 2014. The cases before June 2014 that were originally diagnosed as FVPTC were reviewed and reclassified as NIFTP for the purposes of the current study (27 of 51 total NIFTP cases). Our histologic reports over this 4-year span routinely commented on whether a tumor showed evidence of invasion and/or encapsulation. In addition, to ensure proper categorization, all surgical cases evaluated from June 2014 onward were also reviewed to confirm the diagnoses. The diagnostic criteria of NIFTP were based on those reported in the literature. 2 Briefly, the diagnostic parameters for NIFTP included complete tumor encapsulation with clear demarcation from adjacent benign thyroid tissue, no capsular or vascular invasion, a follicular growth pattern with no papillae formation, and variable degrees of nuclear features of PTC, including enlargement, crowding/overlapping, elongation, irregular contours, grooves, pseudoinclusions, and chromatin clearing. Similar lesions with nuclear features as previously described with encapsulation and only rare foci of capsular invasion and/or evidence of vascular invasion were categorized as the IEFVPTC subtype. Tumors demonstrating an infiltrative microfollicular growth pattern and nuclear features of PTC but without papillae were characterized as the infiltrative FVPTC subtype. Thirty-two cases were excluded from the initial data set; they included 17 cases in which the dominant nodule was a lesion other than an FVPTC subtype, 9 cases in which corresponding preoperative FNA of the dominant nodule had not been performed, and 6 cases for which surgical slides were unavailable for review. As a result, a total of 93 cases were included in the current study. Clinical and radiologic records were also reviewed to ensure that
Original Article the preoperative FNA material corresponded to the location of the dominant FVPTC nodule. The 93 study cases were approximately 70% inhouse cases processed at the Yale-New Haven Hospital and 30% consult cases. In-house FNA was performed under ultrasound guidance with 25-gauge needles. Both air-dried, Diff-Quik-stained (Dade Behring, Deerfield, Illinois) and alcohol-fixed, Papanicolaou-stained direct smears were prepared. Needles were rinsed in CytoRich Red solution (Thermo Fisher Scientific) for a ThinPrep liquid-based preparation (Hologic, Marlborough, Massachusetts). Outside material was submitted as 1 or more of the following: Diff-Quik-stained, Papanicolaou-stained, or hematoxylin-eosin-stained slides; ThinPrep preparations; and cell block materials.
The clinical parameters, cytomorphologic characteristics, cytologic and histologic diagnoses, T and N classifications (American Joint Commission on Cancer staging), 15 surgical margin status, extent of surgery, surgical indications, and molecular testing for BRAF gene mutations were collected for all cases. Cytology diagnoses based on TBSRTC were rendered by board-certified cytopathologists; the majority of these cases were reviewed prospectively at a daily cytopathology consensus conference by 3 or more cytopathologists. All cytopathologists at our institution used a standard template form for reporting thyroid FNA. The forms recorded the cytomorphologic findings of each nodule. When > 50% of the groups in the cytologic material showed a microfollicular arrangement, the case was labeled as having a predominantly microfollicular pattern. Nuclear enlargement, elongation, irregular contours, grooves, and chromatin clearing were considered present when a quantitative threshold of >10% of follicular cells showing the cytologic characteristic was met. 16 Pseudo-inclusions were regarded as present when 1 or more were identified in the specimen. There were only 3 consult FNA cases subsequently diagnosed as NIFTP on surgical resection for which the records were incomplete. Cytomorphologic features were not evaluated for these 3 cases and were excluded from the cytomorphologic statistical analysis. At our institution, TBSRTC diagnoses were reported in the following categories: nondiagnostic/unsatisfactory, benign, AUS/FLUS, follicular neoplasm, suspicious for malignancy, and positive for malignancy. Notably, the AUS/FLUS category was further subclassified into 2 subcategories: those with nuclear atypia and those with architectural atypia only (ie, low cellularity with either a predominantly microfollicular pattern or a H€ urthle cell appearance as well as little colloid and no nuclear atypia). The Stata statistical software program (Stata 13.1; StataCorp, College Station, Texas) was used for all statistical analyses. Univariate analysis was used to compare the clinical, cytomorphologic, and pathologic features among NIFTP, IEFVPTC, and FVPTC subtypes. In addition, comparisons of cytomorphologic characteristics and mutational status were performed between the noninvasive (NIFTP) and invasive diagnostic groups (IEFVPTC and FVPTC). Continuous variables were analyzed with the independent-sample t test and a 1-way analysis of variance (ANOVA), as appropriate. Categorical variables were studied with Fisher's exact test. Statistical significance was defined as P < .05. A multivariate analysis was then performed to identify independent predictors of an NIFTP diagnosis with logistic regression. The cytomorphologic features with P values < .01 in the univariate analysis as well as age and sex were considered in the multivariate analysis.
RESULTS
The 93 patients included in the study had a mean age of 49 years (range, 11-73 years), and 76% were female. There were 51 NIFTP (noninvasive) cases, and the remaining 42 cases were divided between IEFVPTC and infiltrative FVPTC. The clinical, pathologic, and molecular characteristics for the 3 subtypes are summarized in Table 1 . There were no statistically significant differences in mean age (P 5 .322), sex distribution (P 5 .202), tumor size (P 5 .423), or T classification (P 5 .211) among the NIFTP and invasive groups. The difference in the percentage of lymph node metastases (N0 vs N1), however, was statistically significant (P < .001) across the groups.
In addition, we noted that 1 case in our cohort had a positive surgical margin at the time of resection. This finding occurred for a single infiltrative FVPTC case, which was initially called a follicular lesion of undetermined significance at the time of preoperative FNA. This patient underwent initial lobectomy in 2016, which was followed by completion lobectomy soon afterwards. The completion specimen demonstrated an incidental papillary thyroid microcarcinoma (0.2 cm) in the other lobe. The patient had no evidence of vascular or lymphatic invasion on final thyroid pathology; however, the patient's radioactive iodine scan showed uptake in a lymph node distribution pattern. The patient was treated with radioactive iodine and was disease-free at the time of this writing.
When cytomorphologic characteristics of noninvasive (NIFTP) and invasive cases were compared, a predominance of microfollicles (P 5 .007) and a lack of pseudoinclusions (P 5 .005) were significantly associated with NIFTP, whereas nuclear elongation (P 5 .027) and grooves (P 5 .011) were less frequently observed in NIFTP (Table 2 ). When only NIFTP and IEFVPTC subtypes were compared, a microfollicular pattern (P 5 .022) and grooves (P 5 .018) were more likely to be associated with NIFTP, whereas no significant statistical differences were observed for nuclear pseudo-inclusions (P 5 .065) and elongation (P 5 .387) between the 2 entities ( Table 2) . Examples of cytomorphologic features and comparative histologies for each follicular-patterned tumor subtype are shown in Figures 1 (FVPTC) , 2 (IEFVPTC), and 3 (NIFTP). According to the multivariate analysis, a predominance of microfollicles and a lack of nuclear 
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pseudo-inclusions were independent predictors of a subsequent histologic diagnosis of NIFTP (Table 3) . BRAF V600E mutations were most frequently observed in infiltrative FVPTC (25%), which was followed by IEFVPTC (12.5%) and NIFTP (0%). The difference in the frequency of BRAF V600E mutations between noninvasive and invasive subtypes was statistically significant (P 5 0.007). Although none of the NIFTP cases demonstrated a BRAF V600E mutation, we detected other BRAF mutation variants: K601E and V600M.
The preoperative FNA diagnoses of the 93 cases are summarized in Figure 4 . Forty-three NIFTP cases (84%) had an indeterminate FNA diagnosis; they included 18 (35.3%) with an AUS/FLUS diagnosis (17 with nuclear atypia and 1 not otherwise specified), 14 (27.5%) with a follicular neoplasm diagnosis, and 11 (21.6%) with a suspicious-for-malignancy diagnosis. No cases were interpreted as positive for malignancy preoperatively. This is in contrast to the invasive group, in which almost half of the cases (45.2%) were interpreted as either suspicious or positive for malignancy by FNA.
Total thyroidectomy was performed less frequently for NIFTP cases (51.0% or 26 of 51) versus invasive cases (73.8% or 31 of 42). Table 4 summarizes the indications for surgery in our study cases. A cytologic diagnosis alone was cited as an indication for surgery in 43.2% and 52.3% of NIFTP and invasive FVPTC subtype cases, respectively. A diagnosis of goiter was the second most frequent reason and accounted for 33% and 23.8% of NIFTP and invasive cases, respectively.
DISCUSSION
In addition to the presence of complete encapsulation and a follicular growth pattern, the criteria for a NIFTP diagnosis are contingent on the presence of nuclear features of PTC. 2 Because of the recent change in terminology, there is little information regarding the cytologic criteria of NIFTP and how they compare with the cytology of its invasive counterparts. [8] [9] [10] [11] [12] [13] 17 In this study, we have demonstrated that nuclear features of PTC seen on preoperative cytology in cases subsequently diagnosed as NIFTP on resection are less apparent than those seen in invasive FVPTC cases. Furthermore, a predominance of microfollicles and a lack of pseudo-inclusions are independent predictors of a subsequent diagnosis of NIFTP according to a multivariate analysis. Two NIFTP cases (4.2%) in our cohort demonstrated nuclear pseudo-inclusions, which were rare (less than 3 per specimen) and inconspicuous, on cytology. We postulate that rather than merely determining the presence or absence of nuclear pseudo-inclusions, quantifying these cytologic features may be more beneficial in differentiating these entities. Other reports have proposed a cutoff of 3 pseudo-inclusions. 8, 17 Our findings seem to support this proposal. Similarly to our findings, other studies have also reported the presence of a predominantly microfollicular architecture and a paucity of nuclear pseudo-inclusions on the preoperative cytology of NIFTP lesions. 8, 9, 12, 13, 18 One such study by Brandler et al 13 compared the cytomorphologic features of NIFTP, classic PTC, and follicular adenoma and found that all cytologic features evaluated at the time of presurgical FNA were significantly different between classic PTC and NIFTP lesions and that 3 features (nuclear crowding, nuclear enlargement, and nuclear clearing) maintained significance when NIFTP and follicular adenoma were compared. Similarly to our findings, fewer pseudo-inclusions (8.9%) were noted in their NIFTP cohort, and they found that microfollicles were predominant in NIFTP and follicular adenoma lesions (73.2% and 90%, respectively), whereas a predominance of microfollicles was found in only 3% of their classic PTC cases. The findings are not surprising because of the now well-characterized differences between the cytologies of classic PTC and NIFTP lesions. Classic PTC cases demonstrate sheetlike tumor growth, papillae, pseudoinclusions, and a lack of microfollicles in comparison with NIFTP cases. 8, 9, 12 With this knowledge, we sought to understand whether follicular-patterned tumors with potentially more subtle cytomorphologic differences could also be distinguished at the time of preoperative FNA. Others have attempted to examine this question, but it still largely remains unresolved. [10] [11] [12] In one such study, Bizzarro et al 12 compared NIFTP, invasive FVPTC, classic PTC, and follicular adenoma processed by liquid-based cytology, and they found that both NIFTP and invasive FVPTC showed a follicular pattern in 100% of cases. They also found that nuclear size and the presence of nuclear grooves could be helpful cytomorphologic features in distinguishing NIFTP from invasive FVPTC. Nuclear pseudo-inclusions were statistically less apparent in NIFTP cases versus classic PTC cases, but this no longer met significance when NIFTP was compared with the invasive FVPTC subtype. In our cohort, a predominance of microfollicles, nuclear grooves, elongation, and a lack of pseudo-inclusions helped to distinguish NIFTP from the invasive subtypes; however, nuclear enlargement was not statistically significant. Interestingly, Bizzarro et al evaluated nuclear size with the help of an image manipulation program, and our evaluation was performed purely by visualization; this may explain the discrepancy. In addition, Bizzarro et al used liquid-based cytology only, whereas we also evaluated smeared slides. Because smears can help to enhance nuclear detail (especially Papanicolaou-stained slides), this disparity in methodology may explain our enhanced detection of subtle differences in nuclear features among similar lesions. We also noted that comparable to our findings, Bizzarro et al found that all NIFTP cases tested from their cohort were BRAF V600E-negative, whereas 38.5% of the invasive FVPTC cases (5 of 13) were BRAF V600E-positive.
12
Our study also included a comparison of NIFTP and IEFVPTC, through which we detected differences in the cytomorphologic findings between the groups. This was in contrast to the study by Maletta et al, 11 who did not report any differences in the cytomorphologic features between NIFTP lesions and the IEFVPTC subtype. The differences in the methodologies used by the 2 studies may partly explain this discrepancy. Maletta et al evaluated nuclear features of PTC as a group, which combined 3 parameters (irregular contours, grooves, and pseudo-inclusions). A score was then assigned to the parameter as a whole: a score of 0 was given if these nuclear features were absent or only minimally present in <50% of cells, and a score of 1 was assigned when these nuclear features were seen in 50% of cells. 11 We, on the other hand, evaluated these nuclear features (ie, irregular contours, grooves, and pseudo-inclusions) individually and required that the feature be observed in >10% of the follicular cells within the specimen. Our findings demonstrated that the difference in the frequency of nuclear grooves between the 2 entities was statistically significant (P 5 .018). We also noted a trend toward fewer pseudo-inclusions in the NIFTP cases versus the IEFVPTC cases; however, the latter did not reach statistical significance (P 5 .065). Irregular contours did not demonstrate any significant difference between the 2 subtypes (P 5 .427). As mentioned earlier, we found that NIFTP cases demonstrated a significantly higher frequency of a predominance of microfollicles than IEFVPTC cases (P 5 .022). Therefore, we concluded that it would be possible to recognize or at least favor a diagnosis of NIFTP versus other invasive follicular-patterned tumors on the basis of preoperative FNA. Our study showed that the most frequent preoperative cytologic diagnosis for NIFTP cases was category 3 of TBSRTC (AUS/FLUS), which was followed by category 4 (follicular neoplasm) and category 5 (suspicious for malignancy). None of the NIFTP cases in our cohort were One implication of this finding is the extent of surgery for patients with an FNA diagnosis of suspicious for malignancy. At some institutions such as ours, total thyroidectomy is usually recommended for patients with a cytologic diagnosis of suspicious for malignancy. As a result, a substantial number of patients who are later found to harbor an NIFTP might be unnecessarily subjected to a more aggressive surgery. 7 Because total thyroidectomy may follow a suspicious cytologic diagnosis at some institutions, it has been recommended that cases with cytomorphologic features suggestive of NIFTP should be classified as a follicular neoplasm with nuclear atypia. We support this recommendation because this approach would minimize the overtreatment of NIFTP lesions. However, we recognize that this recommendation is not universally accepted. Regardless of the diagnostic term used, a diagnostic comment should be included for these cases that mentions the nuclear features identified and notes that the differential diagnosis includes NIFTP. We also recognize the potential downside that a small number of patients might require a second surgery if they are found to have an invasive subtype after the initial lobectomy. We, however, feel that the benefits outweigh the risks in this scenario. Molecular testing has been increasingly applied to guide subsequent management for patients with an equivocal thyroid FNA diagnosis. Interestingly, although there are some conflicting data in the literature, BRAF V600E-positive tumors are generally reported as being associated with more aggressive clinical disease. [19] [20] [21] A recent metaanalysis by Liu et al 20 showed that in addition to a higher TNM stage, lymph node metastases and the recurrence status correlate with the presence of a BRAF V600E mutation. Although we have limited follow-up data regarding our cohort of cases, we do note that although the T classification was not statistically different between the groups, lymph node metastases and BRAF positivity were detected more often in the invasive FVPTC cases versus the NIFTP cases. In addition, the only case with a positive surgical margin was also an infiltrative FVPTC. Overall, we believe that these differences most likely reflect the underlying biological nature of these tumor types, with the NIFTPs demonstrating a more indolent behavior than the more aggressive FVPTC subtypes. Interestingly, BRAF V600E mutations have rarely been reported in NIFTP cases. [22] [23] [24] cases, which showed predominantly RAS mutations and no BRAF V600E mutations. Even in the study by Zhao et al 22 that identified 1 NIFTP case with a BRAF V600E mutation, the authors cited that this finding was "unusual" and raised the possibility of a sampling error by explaining that "we cannot entirely exclude the possibility of a minor unsampled component of classical PTC within some of our cohort cases." We agree that it is unlikely that NIFTPs will ultimately be shown to harbor BRAF V600E mutations when strict diagnostic criteria are applied. Unlike BRAF V600E-positive tumors, which are associated with aggressiveness and higher clinical stages, NIFTPs have been shown to have an indolent trajectory even after many years of follow-up. 19, 20, [26] [27] [28] [29] We, however, cannot completely discount the possibility that there may be regional or ethnic differences in BRAF V600E positivity in follicular-patterned tumors. In a Korean cohort, Lee et al 23 identified BRAF V600E positivity in 31.8% and 39.1% of NIFTP and encapsulated FVPTC cases, respectively, where BRAF V600E is known to be highly prevalent. More studies will need to be performed to definitively address this question. It is interesting to note that 2 of our NIFTP cases were found to harbor BRAF mutation variants. One of these variants was the BRAF K601E mutation, which had previously been reported to show a less aggressive phenotype in comparison with those tumors with BRAF V600E mutations. 19, 29, 30 We could not find any other reports of a BRAF V600M mutation detected in thyroid tumors in the literature, so its clinical significance remains uncertain. Our study had several limitations, including the modest sample size and its retrospective nature. In addition, for surgical specimens submitted before June 2014, submitting the entire tumor capsule for histologic examination was not a routine practice. As a result, we were not able to evaluate the entire tumor capsule in some of the cases that were redesignated as NIFTP. In addition, we recognize that diagnosing FVPTC histologically is notoriously difficult with considerable interobserver variability even among expert endocrine pathologists. 31, 32 Similarly, we expect this to also hold true for the diagnosis of NIFTP, and the reliability of our analyses is contingent on the accuracy of the histologic classification into various subtypes. In contrast to other recently published studies, we also note that we did not include follicular lesions (follicular adenoma/follicular carcinoma) and adenomatous goiters for comparison with NIFTPs within our cohort; this is a potential shortcoming of our methodology. 8, [11] [12] [13] 26 Despite these limitations, our findings are comparable to those of the few studies on NIFTP cytomorphology published in the literature to date. 8, 9, [11] [12] [13] 18 In conclusion, our study shows that a predominance of microfollicles and a lack of pseudo-inclusions are independent cytologic predictors of NIFTP and thereby can help to differentiate this newly designated entity from its invasive counterparts. Therefore, it would be possible to at least raise the possibility of NIFTP in the differential diagnosis from a preoperative FNA specimen. More importantly, this information should be communicated to the clinicians to facilitate subsequent patient management and surgical decision-making.
